FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paul Perrotte

Research Profile

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Firas Abdollah; Alberto Briganti; Giorgio Gandaglia; Claudio Jeldres; Pierre I Karakiewicz; Francesco Montorsi; Niccolò Maria Passoni; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Rodolphe Thuret; Zhe Tian; Maxine Sun
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis.
Ahmed Alasker; Marco Bianchi; Nawar Hanna; Jens Hansen; Salima Ismail; Malek Meskawi; Paul Perrotte; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma.
Quoc-Dien Trinh; Kevin C Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse D Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paul Perrotte (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Firas Abdollah; Alberto Briganti; Giorgio Gandaglia; Claudio Jeldres; Pierre I Karakiewicz; Francesco Montorsi; Niccolò Maria Passoni; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Rodolphe Thuret; Zhe Tian; Maxine Sun
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis.
Cancer epidemiology 2013;37(3):219-25.
2013: Ahmed Alasker; Marco Bianchi; Nawar Hanna; Jens Hansen; Salima Ismail; Malek Meskawi; Paul Perrotte; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma.
Cancer treatment reviews 2013;39(4):388-401.
2013: Quoc-Dien Trinh; Kevin C Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse D Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy.
Annals of surgical oncology 2013;20(6):2096-102.
2013: Quoc-Dien Trinh; Zhe Tian; Firas Abdollah; Marco Bianchi; Jens Hansen; Pierre I Karakiewicz; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Maxine Sun
In-hospital Mortality and Failure to Rescue After Cytoreductive Nephrectomy.
European urology 2013;63(6):1107-14.
2013: Maxine Sun; Quoc-Dien Trinh; Malek Meskawi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Jens Hansen; Pierre I Karakiewicz
An evidence-based guide to the selection of sequential therapies in metastatic renal cell carcinoma.
Therapeutic advances in urology 2013;5(2):121-8.
2013: Jesse D Sammon; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Marco Bianchi; Khurshid R Ghani; Jim C Hu; Pierre I Karakiewicz; Mani Menon; James O Peabody; Paul Perrotte; Praful Ravi; Quoc-Dien Trinh
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach.
The Journal of urology 2013;189(4):1289-94.
2013: Firas Abdollah; Alberto Briganti; Al'a Abdo; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Pelvic lymph node dissection for prostate cancer: adherence and accuracy of the recent guidelines.
International journal of urology : official journal of the Japanese Urological Association 2013;20(4):405-10.
2013: Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Jens Hansen; Giovanni Lughezzani; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
International journal of urology : official journal of the Japanese Urological Association 2013;20(4):372-80.
2013: Rodolphe Thuret; Firas Abdollah; Lars Budaus; Jacques Guiter; François Iborra; Daniel Liberman; Jean-Jacques Patard; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Pierre I Karakiewicz
A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis.
Cancer causes & control : CCC 2013;24(1):71-9.
2013: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Nawar Hanna; Jens Hansen; Pierre I Karakiewicz
Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities.
BJU international 2013;111(1):67-73.
2012: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Alberto Briganti; Jens Hansen; Pierre I Karakiewicz
Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer?
The journal of sexual medicine 2012;9(11):2961-9.
2012: Jesse D Sammon; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Marco Bianchi; Orchidee Djahangirian; Michael Ehlert; Khurshid R Ghani; Wooju Jeong; Jay Jhaveri; Mani Menon; Monica Morgan; James O Peabody; Paul Perrotte; Craig G Rogers; Pierre I Karakiewicz
Marital status: a gender-independent risk factor for poorer survival after radical cystectomy.
BJU international 2012;110(9):1301-9.
2012: Quoc-Dien Trinh; Piyush K Agarwal; Marco Bianchi; Khurshid R Ghani; Claudio Jeldres; Wooju Jeong; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Leapfrog volume thresholds and perioperative complications after radical prostatectomy.
Cancer 2012;118(20):4991-8.
2012: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Markus Graefen; Jens Hansen; Francesco Montorsi; Paul Perrotte; Jesse Sammon; Shahrokh F Shariat; Pierre I Karakiewicz
Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis.
European urology 2012;62(4):696-703.
2012: Quoc-Dien Trinh; Piyush K Agarwal; Marco Bianchi; Ali Dabaja; Khurshid R Ghani; Wooju Jeong; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Disparities in access to care at high-volume institutions for uro-oncologic procedures.
Cancer 2012;118(18):4421-6.
2012: Firas Abdollah; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
International journal of urology : official journal of the Japanese Urological Association 2012;19(9):836-44; author reply 844-5.
2012: Firas Abdollah; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: a population-based study.
International journal of radiation oncology, biology, physics 2012;84(1):95-103.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Mani Menon; Francesco Montorsi; Paul Perrotte; Marco Bianchi; Felix K Chun; Roland Dahlem; Margit Fisch; Markus Graefen; Jens Hansen; Claudio Jeldres; Pierre I Karakiewicz
Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
BJU international 2012;110(6 Pt B):E183-90.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Lars Budäus; Markus Graefen; Mani Menon; Francesco Montorsi; Paul Perrotte; Georg Salomon; Thorsten Schlomm; Pierre I Karakiewicz
Venous thromboembolism after radical prostatectomy: the effect of surgical caseload.
BJU international 2012;110(6):828-33.
2012: Marco Bianchi; Alberto Briganti; Markus Graefen; Claudio Jeldres; Mani Menon; Malek Meskawi; Francesco Montorsi; James O Peabody; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Pierre I Karakiewicz
Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2012;6(4):245-50.
2012: Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Quoc-Dien Trinh; Marco Bianchi; Alberto Briganti; Khurshid R Ghani; Claudio Jeldres; Mani Menon; Francesco Montorsi; James O Peabody; Paul Perrotte; Craig G Rogers; Pierre I Karakiewicz
The effect of gender on nephrectomy perioperative outcomes: a national survey.
The Canadian journal of urology 2012;19(4):6337-44.
2012: Jens Hansen; Marco Bianchi; Felix K-H Chun; Markus Graefen; Nawar Hanna; Malek Meskawi; Paul Perrotte; Michael Rink; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy.
Urology 2012;80(2):347-53.
2012: Malek Meskawi; Francesco Montorsi; Paul Perrotte; Michael Rink; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Marco Bianchi; Jens Hansen; Salima Ismail; Pierre I Karakiewicz
A review of integrated staging systems for renal cell carcinoma.
European urology 2012;62(2):303-14.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Does partial nephrectomy at an academic institution result in better outcomes?
World journal of urology 2012;30(4):505-10.
2012: Firas Abdollah; Marco Bianchi; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
The Journal of urology 2012;188(1):73-83.
2012: Firas Abdollah; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
International journal of urology : official journal of the Japanese Urological Association 2012;19(7):645-51.
2012: Maxine Sun; Rodolphe Thuret; Zhe Tian; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
Treatment management of small renal masses in the 21st century: a paradigm shift.
Annals of surgical oncology 2012;19(7):2380-7.
2012: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Alberto Briganti; Markus Graefen; Jens Hansen; Claudio Jeldres; Pierre I Karakiewicz
Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy.
European journal of cancer (Oxford, England : 1990) 2012;48(10):1503-11.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.
BJU international 2012;110(2 Pt 2):E21-7.
2012: Jan Schmitges; Shahrokh F Shariat; Thomas Steuber; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Sascha A Ahyai; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy.
International urology and nephrology 2012;44(3):799-806.
2012: Maxine Sun; Zhe Tian; Hugues Widmer; Kevin Zorn; Firas Abdollah; Marco Bianchi; Markus Graefen; Francesco Montorsi; Paul Perrotte; Daniel Pharand; Jan Schmitges; Shahrokh F Shariat; Pierre I Karakiewicz
Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA.
BJU international 2012;109(12):1807-12.
2012: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Open radical prostatectomy in the elderly: a case for concern?
BJU international 2012;109(9):1335-40.
2012: Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Firas Abdollah; Marco Bianchi; Lars Budäus; Christian Eichelberg; Markus Graefen; Jens Hansen; Mani Menon; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy.
Urology 2012;79(4):796-803.
2012: Marco Bianchi; Alberto Briganti; Khurshid R Ghani; Claudio Jeldres; Mani Menon; Francesco Montorsi; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Quoc-Dien Trinh; Pierre I Karakiewicz
Discharge patterns after radical cystectomy: contemporary trends in the United States.
The Journal of urology 2012;187(4):1206-9.
2012: Nawar Hanna; Jens Hansen; Marco Bianchi; Markus Graefen; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Quoc-Dien Trinh; Pierre I Karakiewicz
Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series.
European urology 2012;61(4):715-21.
2012: Maxine Sun; Quoc-Dien Trinh; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Firas Abdollah; Marco Bianchi; Alberto Briganti; Nawar Hanna; Jens Hansen; Pierre I Karakiewicz
A non-cancer-related survival benefit is associated with partial nephrectomy.
European urology 2012;61(4):725-31.
2012: Quoc-Dien Trinh; Kevin Zorn; Marco Bianchi; Markus Graefen; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Pierre I Karakiewicz
Morbidity and mortality of radical prostatectomy differs by insurance status.
Cancer 2012;118(7):1803-10.
2012: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United States.
Cancer 2012;118(7):1894-900.
2012: Al'a Abdo; Marco Bianchi; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Craig G Rogers; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Quoc-Dien Trinh; Kevin Zorn; Pierre I Karakiewicz
The effect of insurance status on outcomes after partial nephrectomy.
International urology and nephrology 2012;44(2):343-51.
2012: Firas Abdollah; Orchidee Djahangirian; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
BJU international 2012;109(8):1147-54.
2012: Firas Abdollah; Alberto Briganti; Al'a Abdo; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
A population-based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy.
BJU international 2012;109(8):1177-82.
2012: Jan Schmitges; Maxine Sun; Quoc-Dien Trinh; Paul Perrotte; Thorsten Schlomm; Firas Abdollah; Marco Bianchi; Lars Budäus; Markus Graefen; Jens Hansen; Claudio Jeldres; Pierre I Karakiewicz
Blood transfusions in radical prostatectomy: a contemporary population-based analysis.
Urology 2012;79(2):332-8.
2012: Firas Abdollah; Orchidee Djahangirian; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
BJU international 2012;109(4):564-9.
2012: Philipp Nuhn; Paul Perrotte; Maxine Sun; Derya Tilki; Lutz Trojan; Wolf F Wieland; Christian Bolenz; Sabine Brookman-May; Alexander Buchner; Maximilian Burger; Hans-Martin Fritsche; Axel Haferkamp; Edwin Herrmann; Markus Hohenfellner; Pierre I Karakiewicz; Matthias May; Rudolf Moritz; Stefan C Müller; Patrick J Bastian
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
European urology 2012;61(1):58-64.
2011: Firas Abdollah; Alberto Briganti; Orchidee Djahangirian; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
Urology 2011;78(6):1363-7.
2011: Maxine Sun; Zhe Tian; Quoc-Dien Trinh; Hugues Widmer; Kevin Zorn; Firas Abdollah; Marco Bianchi; Claudio Jeldres; Mani Menon; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis.
European urology 2011;60(6):1152-9.
2011: Firas Abdollah; Alberto Briganti; Umberto Capitanio; Andrea Gallina; Francesco Montorsi; Paul Perrotte; Patrizio Rigatti; Andrea Salonia; Jan Schmitges; Shahrokh F Shariat; Nazareno Suardi; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy.
BJU international 2011;108(11):1769-75.
2011: Quoc-Dien Trinh; Marco Bianchi; Markus Graefen; Claudio Jeldres; Mani Menon; James O Peabody; Paul Perrotte; Jesse Sammon; Jan Schmitges; Shahrokh F Shariat; Shyam Sukumar; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Radical prostatectomy at academic versus nonacademic institutions: a population based analysis.
The Journal of urology 2011;186(5):1849-54.
2011: Firas Abdollah; Alberto Briganti; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrohk F Shariat; Maxine Sun; Zhe Tian; Pierre I Karakiewicz
Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.
European urology 2011;60(5):920-30.
2011: Maxine Sun; Zhe Tian; Firas Abdollah; Lars Budaüs; Markus Greafen; Rupinder Johal; Daniel Liberman; Francesco Montorsi; Monica Morgan; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Pierre I Karakiewicz
Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.
Annals of surgical oncology 2011;18(10):2997-3004.
2011: Firas Abdollah; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.
Annals of surgical oncology 2011;18(10):2988-96.
2011: Maxine Sun; Rodolphe Thuret; Zhe Tian; Al'a Abdo; Firas Abdollah; Daniel Liberman; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Pierre I Karakiewicz
Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis.
Cancer 2011;117(18):4277-85.
2011: Firas Abdollah; Orchidee Djahangirian; Markus Graefen; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study.
The Journal of urology 2011;186(3):824-8.
2011: Firas Abdollah; Orchidee Djahangirian; Claudio Jeldres; Francesco Montorsi; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Zhe Tian; Pierre I Karakiewicz
Surgical caseload is an important determinant of continent urinary diversion rate at radical cystectomy: a population-based study.
Annals of surgical oncology 2011;18(9):2680-7.
2011: Lars Budäus; Markus Graefen; Alexander Haese; Hendrik Isbarn; Rupinder Johal; Firas Abdollah; Giovanni Lughezzani; Francesco Montorsi; Monica Morgan; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Kevin C Zorn; Pierre I Karakiewicz
The impact of surgical experience on total hospital charges for minimally invasive prostatectomy: a population-based study.
BJU international 2011;108(6):888-93.
2011: Rodolphe Thuret; Firas Abdollah; Jacques Guiter; François Iborra; Jean-Jacques Patard; Paul Perrotte; Jan Schmitges; Shahrokh F Shariat; Maxine Sun; Pierre I Karakiewicz
Conditional survival predictions after surgery for patients with penile carcinoma.
Cancer 2011;117(16):3723-30.
2011: Firas Abdollah; Claudio Jeldres; Al'a Abdo; Francesco Montorsi; Monica Morgan; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Rodolphe Thuret; Pierre I Karakiewicz
The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study.
Cancer causes & control : CCC 2011;22(8):1085-95.
2011: Firas Abdollah; Maxine Sun; Shahrokh F Shariat; Jan Schmitges; Orchidee Djahangirian; Zhe Tian; Claudio Jeldres; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.
The Journal of urology 2011;185(6):2078-84.
2011: L Budäus; M Morgan; F Abdollah; K C Zorn; M Sun; R Johal; R Thuret; A Abdo; J Schmitges; H Isbarn; Claudio Jeldres; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Impact of annual surgical volume on length of stay in patients undergoing minimally invasive prostatectomy: a population-based study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2011;37(5):429-34.
2011: R Thuret; C Maurin; M Sun; Paul Perrotte; Pierre I Karakiewicz
[Treatment of metastatic renal cell carcinoma].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2011;21(4):233-44.
2011: Daniel Liberman; Giovanni Lughezzani; Maxine Sun; Ahmed Alasker; Rodolphe Thuret; Firas Abdollah; Lars Budaus; Hugues Widmer; Markus Graefen; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Pierre I Karakiewicz
Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.
Urology 2011;77(3):660-6.
2011: Firas Abdollah; Lars Budäus; Maxine Sun; Monica Morgan; Rupinder Johal; Rodolphe Thuret; Kevin C Zorn; Hendrik Isbarn; Alexander Haese; Claudio Jeldres; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Impact of caseload on total hospital charges: a direct comparison between minimally invasive and open radical prostatectomy--a population based study.
The Journal of urology 2011;185(3):855-61.
2011: Lars Budäus; Maxine Sun; Firas Abdollah; Kevin C Zorn; Monica Morgan; Rupinder Johal; Daniel Liberman; Rodolphe Thuret; Hendrik Isbarn; Georg Salomon; Alexander Haese; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Impact of surgical experience on in-hospital complication rates in patients undergoing minimally invasive prostatectomy: a population-based study.
Annals of surgical oncology 2011;18(3):839-47.
2011: Daniel Liberman; Ahmed Alasker; Maxine Sun; Salima Ismail; Giovanni Lughezzani; Claudio Jeldres; Lars Budaus; Rodolphe Thuret; Shahrokh F Shariat; Hugues Widmer; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study.
BJU international 2011;107(6):905-11.
2011: Rodolphe Thuret; Maxine Sun; Firas Abdollah; Lars Budaus; Giovanni Lughezzani; Daniel Liberman; Monica Morgan; Rupinder Johal; Claudio Jeldres; Mathieu Latour; Shahrokh F Shariat; François Iborra; Jacques Guiter; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.
The Journal of urology 2011;185(2):501-7.
2011: Rodolphe Thuret; Maxine Sun; Giovanni Lughezzani; Lars Budaus; Daniel Liberman; Firas Abdollah; Monica Morgan; Rupinder Johal; Claudio Jeldres; Mathieu Latour; Shahrokh F Shariat; François Iborra; Jacques Guiter; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma.
Annals of surgical oncology 2011;18(2):439-46.
2011: Maxine Sun; Rodolphe Thuret; Firas Abdollah; Giovanni Lughezzani; Jan Schmitges; Zhe Tian; Shahrokh F Shariat; Francesco Montorsi; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.
European urology 2011;59(1):135-41.
2011: Firas Abdollah; Maxine Sun; Rodolphe Thuret; Claudio Jeldres; Zhe Tian; Alberto Briganti; Shahrokh F Shariat; Paul Perrotte; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006.
European urology 2011;59(1):88-95.
2011: Giovanni Lughezzani; Maxine Sun; Shahrokh F Shariat; Lars Budäus; Rodolphe Thuret; Claudio Jeldres; Daniel Liberman; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer.
Cancer 2011;117(1):103-9.
2010: Maxine Sun; Al'a Abdo; Firas Abdollah; Jan Schmitges; Rodolphe Thuret; Claudio Jeldres; Shahrokh F Shariat; Paul Perrotte; Pierre I Karakiewicz
Management of upper urinary tract urothelial carcinoma.
Expert review of anticancer therapy 2010;10(12):1955-65.
2010: Lars Budäus; Firas Abdollah; Maxine Sun; Monica Morgan; Rupinder Johal; Rodolphe Thuret; Kevin C Zorn; Hendrik Isbarn; Shahrokh F Shariat; Francesco Montorsi; Paul Perrotte; Markus Graefen; Pierre I Karakiewicz
Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends.
The Journal of urology 2010;184(6):2285-90.
2010: Firas Abdollah; Maxine Sun; Rodolphe Thuret; Lars Budäus; Claudio Jeldres; Markus Graefen; Alberto Briganti; Paul Perrotte; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.
European urology 2010;58(6):882-92.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Ahmed Alasker; Claudio Jeldres; Hendrik Isbarn; Lars Budäus; Jean-Baptiste Lattouf; Luc Valiquette; François Bénard; Fred Saad; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Comparative study of inguinal hernia repair rates after radical prostatectomy or external beam radiotherapy.
International journal of radiation oncology, biology, physics 2010;78(5):1307-13.
2010: Maxime Crépel; Claudio Jeldres; Maxine Sun; Giovanni Lughezzani; Hendrik Isbarn; Ahmed Alasker; umberto capitanio; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
Urology 2010;76(4):883-8.
2010: Lars Budäus; Hendrik Isbarn; Christian Eichelberg; Giovanni Lughezzani; Maxine Sun; Paul Perrotte; fianceeyi chun; Georg Salomon; Thomas Steuber; Jens Köllermann; Guido Sauter; Sascha A Ahyai; Mario Zacharias; Margit Fisch; Thorsten Schlomm; Alexander Haese; Hans Heinzer; Hartwig Huland; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage.
The Journal of urology 2010;184(4):1341-6.
2010: Claudio Jeldres; Maxine Sun; Giovanni Lughezzani; Hendrik Isbarn; Shahrokh F Shariat; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
Cancer 2010;116(16):3774-84.
2010: Giovanni Lughezzani; Pierre I Karakiewicz; Pierre Bigot; Paul Perrotte; Maxime Crépel; Nathalie Rioux-Leclercq; Véronique Catros-Quemener; Jacques-Philippe Moulinoux; Françoise Bouet; Bernard Cipolla; Jean-Jacques Patard
The prognostic value of erythrocyte polyamines in the preoperative evaluation of patients with renal cell carcinoma.
European journal of cancer (Oxford, England : 1990) 2010;46(10):1927-35.
2010: Hendrik Isbarn; Pierre I Karakiewicz; Susanne Vogel; Claudio Jeldres; Giovanni Lughezzani; Alberto Briganti; Francesco Montorsi; Paul Perrotte; Sascha A Ahyai; Lars Budäus; Christian Eichelberg; Roman Heuer; Jens Köllermann; Guido Sauter; Thorsten Schlomm; Thomas Steuber; Alexander Haese; Mario Zacharias; Margit Fisch; Hans Heinzer; Hartwig Huland; fianceeyi chun; Markus Graefen
Unilateral prostate cancer cannot be accurately predicted in low-risk patients.
International journal of radiation oncology, biology, physics 2010;77(3):784-7.
2010: Giovanni Lughezzani; Maxine Sun; Lars Budäus; Rodolphe Thuret; Paul Perrotte; Pierre I Karakiewicz
Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(18):e299-300; author reply e301.
2010: Claudio Jeldres; Maxine Sun; Paul Perrotte; Pierre I Karakiewicz
Pazopanib trial data cannot support first-line use.
Nature reviews. Urology 2010;7(6):307-8.
2010: Maxine Sun; Giovanni Lughezzani; Paul Perrotte; Pierre I Karakiewicz
Treatment of metastatic renal cell carcinoma.
Nature reviews. Urology 2010;7(6):327-38.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Lars Budaus; Ahmed Alasker; AJ Duclos; Hugues Widmer; Mathieu Latour; Giorgio Guazzoni; Francesco Montorsi; Pierre I Karakiewicz
Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study.
European urology 2010;57(6):956-62.
2010: Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Hendrik Isbarn; Shahrokh F Shariat; Lars Budaus; Jean-Baptiste Lattouf; Hugues Widmer; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter.
The Journal of urology 2010;183(4):1324-9.
2010: Giovanni Lughezzani; Lars Budäus; Hendrik Isbarn; Maxine Sun; Paul Perrotte; Alexander Haese; fianceeyi chun; Thorsten Schlomm; Thomas Steuber; Hans Heinzer; Hartwig Huland; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
European urology 2010;57(4):562-8.
2010: Giovanni Lughezzani; Maxine Sun; Lars Budäus; Rodolphe Thuret; Shahrokh F Shariat; Paul Perrotte; Pierre I Karakiewicz
Effect of the number of biopsy cores on prostate cancer detection and staging.
Future oncology (London, England) 2010;6(3):381-90.
2010: Sascha A Ahyai; Hendrik Isbarn; Pierre I Karakiewicz; fianceeyi chun; Mathias Reichert; Jochen Walz; Thomas Steuber; Claudio Jeldres; Thorsten Schlomm; Hans Heinzer; Georg Salomon; Lars Budäus; Paul Perrotte; Hartwig Huland; Markus Graefen; Alexander Haese
The presence of prostate cancer on saturation biopsy can be accurately predicted.
BJU international 2010;105(5):636-41.
2010: Maxine Sun; Giovanni Lughezzani; Ahmed Alasker; Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Lars Budäus; Jean-Baptiste Lattouf; Luc Valiquette; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection.
The Journal of urology 2010;183(3):970-5.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Claudio Jeldres; Ahmed Alasker; Hendrik Isbarn; Lars Budäus; Shahrokh F Shariat; Giorgio Guazzoni; Francesco Montorsi; Pierre I Karakiewicz
The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation.
European journal of cancer (Oxford, England : 1990) 2010;46(4):713-9.
2010: Hendrik Isbarn; Pierre I Karakiewicz; Sascha A Ahyai; fianceeyi chun; Claudio Jeldres; Alexander Haese; Hans Heinzer; Mario Zacharias; Roman Heuer; Christian Eichelberg; Thomas Steuber; Lars Budäus; Jens Köllermann; Georg Salomon; Thorsten Schlomm; Paul Perrotte; Margit Fisch; Hartwig Huland; Markus Graefen
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.
BJU international 2010;105(6):818-23.
2010: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Maxine Sun; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; Markus Graefen; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma.
BJU international 2010;105(6):799-804.
2010: Naeem Bhojani; umberto capitanio; Nazareno Suardi; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Markus Graefen; Philippe Arjane; AJ Duclos; Jean-Baptiste Lattouf; Fred Saad; Luc Valiquette; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.
International journal of radiation oncology, biology, physics 2010;76(2):342-8.
2010: Sara Baillargeon-Gagné; Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Hendrik Isbarn; umberto capitanio; Shahrokh F Shariat; Maxime Crépel; Ahmed Alasker; Hugues Widmer; Philippe Arjane; Jean-Jacques Patard; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
BJU international 2010;105(3):359-64.
2010: Giovanni Lughezzani; Maxine Sun; Claudio Jeldres; Ahmed Alasker; Lars Budäus; Shahrokh F Shariat; Mathieu Latour; Hugues Widmer; AJ Duclos; Martine Jolivet-Tremblay; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
Urology 2010;75(2):376-81.
2010: Pierre Bigot; Giovanni Lughezzani; Pierre I Karakiewicz; Paul Perrotte; Nathalie Rioux-Leclercq; Véronique Catros-Quemener; Françoise Bouet; Jacques-Philippe Moulinoux; Bernard Cipolla; Jean-Jacques Patard
The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality.
The Journal of urology 2010;183(2):486-91.
2010: Claudio Jeldres; Maxine Sun; Hendrik Isbarn; Giovanni Lughezzani; Lars Budäus; Ahmed Alasker; Shahrohk F Shariat; Jean-Baptiste Lattouf; Hugues Widmer; Daniel Pharand; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma.
Urology 2010;75(2):315-20.
2010: Maxime Crépel; Claudio Jeldres; Paul Perrotte; umberto capitanio; Hendrik Isbarn; Shahrokh F Shariat; Daniel Liberman; Maxine Sun; Giovanni Lughezzani; Philippe Arjane; Hugues Widmer; Markus Graefen; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
Urology 2010;75(2):271-5.
2010: Giovanni Lughezzani; Maxine Sun; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Lars Budäus; Mathieu Latour; Hugues Widmer; AJ Duclos; Francois Bénard; Michael McCormack; Francesco Montorsi; Pierre I Karakiewicz
Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
Urology 2010;75(2):321-7.
2010: Christopher R Porter; Nazareno Suardi; Umberto Capitanio; Georg C Hutterer; Koichi Kodama; Robert P Gibbons; Roy Correa; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
A nomogram predicting prostate cancer-specific mortality after radical prostatectomy.
Urologia internationalis 2010;84(2):132-40.
2010: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Maxine Sun; Daniel Pharand; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
Urology 2010;75(1):118-24.
2009: Giovanni Lughezzani; umberto capitanio; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
Cancer 2009;115(24):5680-7.
2009: Catherine Guevremont; Florin I Mija; Hendrik Isbarn; Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Pascale Audet; Paul Perrotte; Pierre I Karakiewicz
Dose escalation of second-line sunitinib results in rapid partial remission of multiple hepatic metastases.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2009;3(6):E92-3.
2009: Claudio Jeldres; Maxine Sun; Daniel Liberman; Giovanni Lughezzani; Alexandre de la Taille; Jacques Tostain; Antoine Valeri; Luca Cindolo; Vincenzo Ficarra; Walter Artibani; Richard Zigeuner; Arnaud Mejean; Jean Luc Descotes; Eric Lechevallier; Peter F Mulders; Paul Perrotte; Jean-Jacques Patard; Pierre I Karakiewicz
Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
The Journal of urology 2009;182(6):2585-9.
2009: Pierre I Karakiewicz; Nazareno Suardi; umberto capitanio; Hendrik Isbarn; Claudio Jeldres; Paul Perrotte; Maxine Sun; Vincenzo Ficarra; Richard Zigeuner; Jacques Tostain; Arnaud Mejean; Luca Cindolo; Allan J Pantuck; Arie S Belldegrun; Laurent Zini; Alexandre de la Taille; Denis Chautard; Jean-Luc Descotes; Shahrokh F Shariat; Antoine Valeri; Peter F A Mulders; Hervé Lang; Eric Lechevallier; Jean-Jacques Patard
Conditional survival predictions after nephrectomy for renal cell carcinoma.
The Journal of urology 2009;182(6):2607-12.
2009: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Maxine Sun; Shahrokh F Shariat; Ahmed Alasker; Daniel Pharand; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
European journal of cancer (Oxford, England : 1990) 2009;45(18):3291-7.
2009: Laurent Zini; umberto capitanio; Claudio Jeldres; Giovanni Lughezzani; Maxine Sun; Shahrokh F Shariat; Hendrik Isbarn; Philippe Arjane; Hugues Widmer; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma.
BJU international 2009;104(11):1661-7.
2009: Vincent Cloutier; umberto capitanio; Laurent Zini; Paul Perrotte; Claudio Jeldres; Shahrokh F Shariat; Philippe Arjane; Jean-Jacques Patard; Francesco Montorsi; Pierre I Karakiewicz
Thirty-day mortality after nephrectomy: clinical implications for informed consent.
European urology 2009;56(6):998-1003.
2009: Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Daniel Liberman; Maxine Sun; Giovanni Lughezzani; Hugues Widmer; Philippe Arjane; Daniel Pharand; Margit Fisch; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
The Journal of urology 2009;182(5):2177-81.
2009: Maxine Sun; Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Daniel Pharand; Mathieu Latour; Paul Perrotte; Jean-Jacques Patard; Pierre I Karakiewicz
A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.
European urology 2009;56(5):775-81.
2009: Giovanni Lughezzani; Claudio Jeldres; Hendrik Isbarn; Paul Perrotte; Shahrokh F Shariat; Maxine Sun; Hugues Widmer; Philippe Arjane; Francois Peloquin; Daniel Pharand; Jean-Jacques Patard; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
The Journal of urology 2009;182(4):1287-93.
2009: Maxime Crépel; Hendrik Isbarn; umberto capitanio; Daniel Liberman; Claudio Jeldres; Maxine Sun; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; Markus Graefen; Francesco Montorsi; Jean-Jacques Patard; Paul Perrotte; Pierre I Karakiewicz
Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?
Urology 2009;74(4):842-5.
2009: Umberto Capitanio; Hendrik Isbarn; Shahrokh F Shariat; Claudio Jeldres; Laurent Zini; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist.
Urology 2009;74(4):858-64.
2009: Claudio Jeldres; Sara Baillargeon-Gagne; Daniel Liberman; Hendrik Isbarn; umberto capitanio; Shahrokh F Shariat; Maxine Sun; Giovanni Lughezzani; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.
Urology 2009;74(4):837-41.
2009: umberto capitanio; Paul Perrotte; Laurent Zini; Claudio Jeldres; Shahrokh F Shariat; Hendrik Isbarn; Philippe Arjane; François Peloquin; Daniel Pharand; Francesco Montorsi; Pierre I Karakiewicz
Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
BJU international 2009;104(6):795-9.
2009: Hendrik Isbarn; Claudio Jeldres; umberto capitanio; Laurent Zini; Shahrokh F Shariat; Giovanni Lughezzani; Maxine Sun; Sascha A Ahyai; AJ Duclos; Martine Jolivet-Tremblay; Jean-Baptiste Lattouf; Luc Valiquette; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy.
Journal of endourology / Endourological Society 2009;23(8):1347-52.
2009: Claudio Jeldres; Hendrik Isbarn; umberto capitanio; Laurent Zini; Naeem Bhojani; Shahrokh F Shariat; Vincent Cloutier; Jean-Baptiste Lattouf; AJ Duclos; Martine Jolivet-Tremblay; Luc Valiquette; Fred Saad; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
The Journal of urology 2009;182(2):626-32.
2009: umberto capitanio; Claudio Jeldres; Paul Perrotte; Hendrik Isbarn; Maxime Crépel; Vincent Cloutier; Sara Baillargeon-Gagne; Shahrokh F Shariat; AJ Duclos; Philippe Arjane; Hugues Widmer; Fred Saad; Francesco Montorsi; Pierre I Karakiewicz
Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors.
Urology 2009;74(2):373-7.
2009: Hendrik Isbarn; Claudio Jeldres; Laurent Zini; Paul Perrotte; Sara Baillargeon-Gagne; umberto capitanio; Shahrokh F Shariat; Phillipe Arjane; Fred Saad; Michael McCormack; Luc Valiquette; Francois Peloquin; AJ Duclos; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
A population based assessment of perioperative mortality after cystectomy for bladder cancer.
The Journal of urology 2009;182(1):70-7.
2009: Claudio Jeldres; Karim Bensalah; Umberto Capitanio; Laurent Zini; Paul Perrotte; Nazareno Suardi; Jacques Tostain; Antoine Valeri; Jean-Luc Descotes; Jean-Jacques Rambeaud; Alexandre de la Taille; Laurent Salomon; Claude Abbou; Jean-Jacques Patard; Pierre I Karakiewicz
Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy.
BJU international 2009;103(12):1632-5.
2009: Claudio Jeldres; Jean-Jacques Patard; umberto capitanio; Paul Perrotte; Nazareno Suardi; Maxime Crepel; Vincenzo Ficarra; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Christian Pfister; Baptiste Albouy; Marc Colombel; Arnaud Méjean; Hervé Lang; Didier Jacqmin; Jean-Christophe Bernhard; Jean-Marie Ferrière; Karim Bensalah; Pierre I Karakiewicz
Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.
Urology 2009;73(6):1300-5.
2009: umberto capitanio; Paul Perrotte; Laurent Zini; Nazareno Suardi; Elie Antebi; Vincent Cloutier; Claudio Jeldres; Shahrokh F Shariat; AJ Duclos; Philippe Arjane; Fred Saad; Francesco Montorsi; Pierre I Karakiewicz
Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort.
Urology 2009;73(6):1323-7.
2009: umberto capitanio; Vincent Cloutier; Laurent Zini; Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Paul Perrotte; Elie Antebi; Jean-Jacques Patard; Francesco Montorsi; Pierre I Karakiewicz
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study.
BJU international 2009;103(11):1496-500.
2009: L Zini; Jean-Jacques Patard; umberto capitanio; Arnaud Mejean; Arnauld Villers; Alexandre de la Taille; Vincenzo Ficarra; M Crepel; R Bertini; Laurent Salomon; Grégory Verhoest; Paul Perrotte; K Bensalah; P Arjane; J Biserte; Francesco Montorsi; Pierre I Karakiewicz
The use of partial nephrectomy in European tertiary care centers.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2009;35(6):636-42.
2009: umberto capitanio; Pierre I Karakiewicz; Luc Valiquette; Paul Perrotte; Claudio Jeldres; Alberto Briganti; Andrea Gallina; Nazareno Suardi; Andrea Cestari; Giorgio Guazzoni; Andrea Salonia; Francesco Montorsi
Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
Urology 2009;73(5):1087-91.
2009: Laurent Zini; Paul Perrotte; umberto capitanio; Claudio Jeldres; Shahrokh F Shariat; Elie Antebi; Fred Saad; Jean-Jacques Patard; Francesco Montorsi; Pierre I Karakiewicz
Radical versus partial nephrectomy: effect on overall and noncancer mortality.
Cancer 2009;115(7):1465-71.
2009: Laurent Zini; Paul Perrotte; Claudio Jeldres; umberto capitanio; AJ Duclos; Martine Jolivet-Tremblay; Philippe Arjane; François Péloquin; Daniel Pharand; Arnauld Villers; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.
BJU international 2009;103(7):899-904; discussion 904.
2009: Laurent Zini; Paul Perrotte; umberto capitanio; Claudio Jeldres; AJ Duclos; Philippe Arjane; Arnauld Villers; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Race affects access to nephrectomy but not survival in renal cell carcinoma.
BJU international 2009;103(7):889-93.
2009: Kevin C Zorn; Umberto Capitanio; Claudio Jeldres; Philippe Arjane; Paul Perrotte; Shahrokh F Shariat; David I Lee; Arieh L Shalhav; Gregory P Zagaja; Sergey A Shikanov; Ofer N Gofrit; Alan E Thong; David M Albala; Leon Sun; Pierre I Karakiewicz
Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables.
International journal of radiation oncology, biology, physics 2009;73(5):1461-7.
2009: Christopher R Porter; Umberto Capitanio; Paul Perrotte; Jochen Walz; Hendrik Isbarn; Koichi Kodama; Robert P Gibbons; RJ Correa; Pierre I Karakiewicz
Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control study.
BJU international 2009;103(5):597-602.
2009: Claudio Jeldres; Nazareno Suardi; Paul Perrotte; umberto capitanio; Jochen Walz; Georg C Hutterer; Fred Saad; Luc Valiquette; Markus Graefen; Hugues Widmer; Pierre I Karakiewicz
Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2009;3(1):13-21.
2009: Laurent Zini; Vincent Cloutier; Hendrik Isbarn; Paul Perrotte; umberto capitanio; Claudio Jeldres; Shahrokh F Shariat; Fred Saad; Philippe Arjane; AJ Duclos; Jean-Baptiste Lattouf; Francesco Montorsi; Pierre I Karakiewicz
A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(3):1013-8.
2009: Laurent Zini; umberto capitanio; Paul Perrotte; Claudio Jeldres; Shahrokh F Shariat; Philippe Arjane; Hugues Widmer; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.
Urology 2009;73(2):342-6.
2009: umberto capitanio; Paul Perrotte; Georg C Hutterer; Nazareno Suardi; Claudio Jeldres; Shahrokh F Shariat; Alain Duclos; Philippe Arjane; Francesco Montorsi; Pierre I Karakiewicz
Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men.
International journal of urology : official journal of the Japanese Urological Association 2009;16(1):91-5.
2008: Pierre I Karakiewicz; Claudio Jeldres; Nazareno Suardi; Georg C Hutterer; Paul Perrotte; umberto capitanio; Vincenzo Ficarra; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Peter F Mulders; Laurent Salomon; Richard Zigeuner; Luigi Schips; Denis Chautard; Antoine Valeri; Eric Lechevallier; Jean-Luc Descots; Herve Lang; Arnaud Mejean; Gregory Verhoest; Jean-Jacques Patard
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2008;2(6):610-7.
2008: Laurent Zini; Paul Perrotte; Claudio Jeldres; umberto capitanio; Daniel Pharand; Philippe Arjane; Steven Lapointe; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma.
BJU international 2008;102(11):1610-4.
2008: umberto capitanio; Sascha A Ahyai; Markus Graefen; Claudio Jeldres; Shahrokh F Shariat; Andreas Erbersdobler; Thorsten Schlomm; Alexander Haese; Thomas Steuber; Hans Heinzer; Paul Perrotte; François Péloquin; Daniel Pharand; Philippe Arjane; Hartwig Huland; Pierre I Karakiewicz
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
Urology 2008;72(6):1208-11; discussion 1212-3.
2008: umberto capitanio; Laurent Zini; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Philippe Arjane; Daniel Pharand; Hugues Widmer; François Péloquin; Francesco Montorsi; Jean-Jacques Patard; Pierre I Karakiewicz
Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
Urology 2008;72(5):1090-5.
2008: Nazareno Suardi; umberto capitanio; Felix K-H Chun; Markus Graefen; Paul Perrotte; Thorsten Schlomm; Alexander Haese; Hartwig Huland; Andreas Erbersdobler; Francesco Montorsi; Pierre I Karakiewicz
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
Cancer 2008;113(8):2068-72.
2008: Christopher R Porter; Nazareno Suardi; Koichi Kodama; Umberto Capitanio; Robert P Gibbons; Roy Correa; Claudio Jeldres; Paul Perrotte; Francesco Montorsi; Pierre I Karakiewicz
A nomogram predicting metastatic progression after radical prostatectomy.
International journal of urology : official journal of the Japanese Urological Association 2008;15(10):889-94.
2008: Pierre I Karakiewicz; Naeem Bhojani; umberto capitanio; Alwyn M Reuther; Nazareno Suardi; Claudio Jeldres; Daniel Pharand; François Péloquin; Paul Perrotte; Shahrokh F Shariat; Eric A Klein
External validation of the updated Partin tables in a cohort of North American men.
The Journal of urology 2008;180(3):898-902; discussion 902-3.
2008: Naeem Bhojani; Paul Perrotte; Georg C Hutterer; Nazareno Suardi; Claudio Jeldres; Shahrokh F Shariat; umberto capitanio; Philippe Arjane; Hugues Widmer; Francois Benard; Francois Peloquin; Francesco Montorsi; Pierre I Karakiewicz
Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening.
The journal of sexual medicine 2008;5(9):2141-51.
2008: Fred Saad; Dean Ruether; Scott Ernst; Scott North; Tina Cheng; Paul Perrotte; Pierre I Karakiewicz; Eric Winquist
The Canadian Uro-Oncology Group multicentre phase II study of docetaxel administered every 3 weeks with prednisone in men with metastatic hormone-refractory prostate cancer progressing after mitoxantrone/prednisone.
BJU international 2008;102(5):551-5.
2008: Claudio Jeldres; Nazareno Suardi; umberto capitanio; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Francois Peloquin; Daniel Pharand; Markus Graefen; Pierre I Karakiewicz
High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer.
BJU international 2008;102(4):463-7.
2008: Andrea Gallina; Nazareno Suardi; Francesco Montorsi; umberto capitanio; Claudio Jeldres; Fred Saad; Markus Graefen; Shahrokh F Shariat; Hugues Widmer; Philippe Arjane; François Péloquin; Paul Perrotte; Pierre I Karakiewicz
Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.
International journal of cancer. Journal international du cancer 2008;123(3):647-52.
2008: Marie Théaudin; Philippe Couvert; Emmanuel Fournier; Daniel Bouige; Eric Bruckert; Paul Perrotte; Yvan Vaschalde; Thierry Maisonobe; Dominique Bonnefont-Rousselot; Alain Carrié; Nadine Le Forestier
Lewis-Sumner syndrome and Tangier disease.
Archives of neurology 2008;65(7):968-70.
2008: Jochen Walz; Nazareno Suardi; Shahrokh F Shariat; Claudio Jeldres; Paul Perrotte; Markus Graefen; Hughes Widmer; Philippe Arjane; Luc Valiquette; Georg C Hutterer; Fred Saad; Pierre I Karakiewicz
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
BJU international 2008;102(1):33-8.
2008: Claudio Jeldres; Nazareno Suardi; Fred Saad; Francesco Montorsi; Shahrokh F Shariat; Paul Perrotte; Naeem Bhojani; Jochen Walz; Georg C Hutterer; Markus Graefen; Luc Valiquette; Pierre I Karakiewicz
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.
European urology 2008;54(1):97-105.
2008: Claudio Jeldres; Nazareno Suardi; Jochen Walz; Fred Saad; Georg C Hutterer; Naeem Bhojani; Shahrokh F Shariat; Paul Perrotte; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
European urology 2008;54(1):107-16.
2008: Jochen Walz; Shahrokh F Shariat; Nazareno Suardi; Paul Perrotte; Yair Lotan; Ganesh S Palapattu; Amit Gupta; Patrick J Bastian; Craig G Rogers; Amnon Vazina; Gilad E Amiel; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner; Pierre I Karakiewicz
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
BJU international 2008;101(11):1356-61.
2008: Andrea Gallina; Felix K-H Chun; Nazareno Suardi; James A Eastham; Paul Perrotte; Markus Graefen; Georg C Hutterer; Hartwig Huland; Eric A Klein; Alwyn M Reuther; Francesco Montorsi; Alberto Briganti; Shahrokh F Shariat; Claus G Roehrborn; Alexandre de la Taille; Laurent Salomon; Pierre I Karakiewicz
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
BJU international 2008;101(12):1513-8.
2008: Naeem Bhojani; Claudio Jeldres; Jean-Jacques Patard; Paul Perrotte; Nazareno Suardi; Georg C Hutterer; François Patenaude; Stéphane Oudard; Pierre I Karakiewicz
Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma.
European urology 2008;53(5):917-30.
2008: Pierre I Karakiewicz; Naeem Bhojani; Alfred I Neugut; Shahrokh F Shariat; Claudio Jeldres; Markus Graefen; Paul Perrotte; Francois Peloquin; Michael W Kattan
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
The journal of sexual medicine 2008;5(4):919-27.
2008: Jochen Walz; Francesco Montorsi; Claudio Jeldres; Nazareno Suardi; Shahrokh F Shariat; Paul Perrotte; Philippe Arjane; Markus Graefen; Daniel Pharand; Pierre I Karakiewicz
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.
BJU international 2008;101(7):826-32.
2008: Pierre I Karakiewicz; Nazareno Suardi; Claudio Jeldres; Pascale Audet; Pierre Ghosn; Jean-Jacques Patard; Paul Perrotte
Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi.
European urology 2008;53(4):845-8.
2008: Shahrokh F Shariat; Jochen Walz; Claus G Roehrborn; Alexandre R Zlotta; Paul Perrotte; Nazareno Suardi; Fred Saad; Pierre I Karakiewicz
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1526-31.
2008: Georg C Hutterer; Pierre I Karakiewicz; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Vincenzo Serretta; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Paul Perrotte; Yair Lotan; Michael J Marberger; Shahrokh F Shariat
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
BJU international 2008;101(5):561-5.
2008: Naeem Bhojani; Paul Perrotte; Claudio Jeldres; Nazareno Suardi; Georg C Hutterer; Shahrokh F Shariat; Pierre I Karakiewicz
The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening.
The journal of sexual medicine 2008;5(3):668-76.
2008: Alberto Briganti; Andrea Gallina; Nazareno Suardi; Felix K-H Chun; Jochen Walz; Roman Heuer; Andrea Salonia; Alexander Haese; Paul Perrotte; Luc Valiquette; Markus Graefen; Patrizio Rigatti; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
BJU international 2008;101(5):556-60.
2008: Jochen Walz; Nazareno Suardi; Georg C Hutterer; Paul Perrotte; Andrea Gallina; Francois Bénard; Luc Valiquette; Michael McCormack; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.
Journal of endourology / Endourological Society 2008;22(2):369-76.
2008: Jochen Walz; Paul Perrotte; Nazareno Suardi; Georg C Hutterer; Claudio Jeldres; François Bénard; Luc Valiquette; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Baseline prevalence of erectile dysfunction in a prostate cancer screening population.
The journal of sexual medicine 2008;5(2):428-35.
2008: Georg C Hutterer; Jean-Jacques Patard; Claudio Jeldres; Paul Perrotte; Alexandre de la Taille; Laurent Salomon; Grégory Verhoest; Jacques Tostain; Luca Cindolo; Vincenzo Ficarra; Walter Artibani; Luigi Schips; Richard Zigeuner; Peter F A Mulders; Pierre I Karakiewicz
Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram.
BJU international 2008;101(1):39-43.
2007: Felix K-H Chun; Nazareno Suardi; Paul Perrotte; Thierry Lebeau; Jean-Pierre Guay; Serge Benayoun; Alvaro Ramirez; François Bénard; Michael McCormack; Luc Valiquette; Pierre I Karakiewicz
Screening men for prostate cancer and colorectal cancer: is practice evidence-based?
The Canadian journal of urology 2007;14(6):3727-33.
2007: Alberto Briganti; Felix K-H Chun; Nazareno Suardi; Andrea Gallina; Jochen Walz; Markus Graefen; Shahrokh F Shariat; Andreas Ebersdobler; Patrizio Rigatti; Paul Perrotte; Fred Saad; Francesco Montorsi; Hartwig Huland; Pierre I Karakiewicz
Prostate volume and adverse prostate cancer features: fact not artifact.
European journal of cancer (Oxford, England : 1990) 2007;43(18):2669-77.
2007: Jochen Walz; Andrea Gallina; Paul Perrotte; Claudio Jeldres; Quoc-Dien Trinh; Georg C Hutterer; Miriam Traumann; Alvaro Ramirez; Shahrokh F Shariat; Michael McCormack; Jean-Paul Perreault; François Bénard; Luc Valiquette; Fred Saad; Pierre I Karakiewicz
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
BJU international 2007;100(6):1254-8.
2007: Jochen Walz; Paul Perrotte; Georg C Hutterer; Nazareno Suardi; Claudio Jeldres; François Bénard; Luc Valiquette; Pierre I Karakiewicz
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.
BJU international 2007;100(6):1307-11.
2007: Andrea Gallina; Alberto Briganti; Felix K-H Chun; Jochen Walz; Georg C Hutterer; Andreas Erbersdobler; Christian Eichelberg; Thorsten Schlomm; Sascha A Ahyai; Paul Perrotte; Fred Saad; Francesco Montorsi; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
BJU international 2007;100(6):1249-53.
2007: Georg C Hutterer; Jean-Jacques Patard; Paul Perrotte; Constantin Ionescu; Alexandre de la Taille; Laurent Salomon; Grégory Verhoest; Jacques Tostain; Luca Cindolo; Vincenzo Ficarra; Walter Artibani; Luigi Schips; Richard Zigeuner; Peter F A Mulders; Antoine Valeri; Denis Chautard; Jean-Luc Descotes; Jean-Jacques Rambeaud; Arnaud Mejean; Pierre I Karakiewicz
Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram.
International journal of cancer. Journal international du cancer 2007;121(11):2556-61.
2007: Pierre I Karakiewicz; Georg C Hutterer; Quoc-Dien Trinh; Claudio Jeldres; Paul Perrotte; Andrea Gallina; Jacques Tostain; Jean-Jacques Patard
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
Cancer 2007;110(6):1241-7.
2007: Vincent Fradet; Christiane Gaudreau; Paul Perrotte; Jean Côté; Jean-Marie Paquin
Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada 2007;1(3):269-72.
2007: Jochen Walz; Andrea Gallina; Georg C Hutterer; Paul Perrotte; Shahrokh F Shariat; Markus Graefen; Michael McCormack; François Bénard; Luc Valiquette; Fred Saad; Pierre I Karakiewicz
Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
International journal of radiation oncology, biology, physics 2007;69(1):88-94.
2007: Jochen Walz; Andrea Gallina; Fred Saad; Francesco Montorsi; Paul Perrotte; Shahrokh F Shariat; Claudio Jeldres; Markus Graefen; François Bénard; Michael McCormack; Luc Valiquette; Pierre I Karakiewicz
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3576-81.
2007: Christopher R Porter; Andrea Gallina; Koichi Kodama; Robert P Gibbons; Roy Correa; Paul Perrotte; Pierre I Karakiewicz
Prostate cancer-specific survival in men treated with hormonal therapy after failure of radical prostatectomy.
European urology 2007;52(2):446-52.
2007: Jochen Walz; Paul Perrotte; Andrea Gallina; François Bénard; Luc Valiquette; Michael McCormack; Francesco Montorsi; Pierre I Karakiewicz
Ejaculatory disorders may affect screening for prostate cancer.
The Journal of urology 2007;178(1):232-7; discussion 237-8.
2007: Felix K-H Chun; Georg C Hutterer; Paul Perrotte; Andrea Gallina; Luc Valiquette; Francois Benard; Michael McCormack; Alberto Briganti; Constantin Ionescu; Claudio Jeldres; Jean-Pierre Guay; Fred Saad; Pierre I Karakiewicz
Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.
BJU international 2007;100(1):37-41.
2007: Pierre I Karakiewicz; Paul Perrotte; Quoc-Dien Trinh; Jean-Jacques Patard
Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8.
European urology 2007;51(6):1478-80.
2007: Quoc-Dien Trinh; Etienne Cardinal; Andrea Gallina; Paul Perrotte; Fred Saad; Pierre I Karakiewicz
Sunitinib relieves renal cell carcinoma spinal cord compression.
European urology 2007;51(6):1741-3.
2007: Georg C Hutterer; Paul Perrotte; Andrea Gallina; Jochen Walz; Claudio Jeldres; Miriam Traumann; Nazareno Suardi; Fred Saad; François Bénard; Luc Valiquette; Michael McCormack; Markus Graefen; Francesco Montorsi; Pierre I Karakiewicz
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
European journal of cancer (Oxford, England : 1990) 2007;43(7):1180-7.
2007: Pierre I Karakiewicz; Alberto Briganti; Felix K-H Chun; Quoc-Dien Trinh; Paul Perrotte; Vincenzo Ficarra; Luca Cindolo; Alexandre de la Taille; Jacques Tostain; Peter F A Mulders; Laurent Salomon; Richard Zigeuner; Tommaso Prayer-Galetti; Denis Chautard; Antoine Valeri; Eric Lechevallier; Jean-Luc Descotes; Herve Lang; Arnaud Mejean; Jean-Jacques Patard
Multi-institutional validation of a new renal cancer-specific survival nomogram.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1316-22.
2007: Felix K-H Chun; Alberto Briganti; Claudio Jeldres; Andreas Erbersdobler; Thorsten Schlomm; Thomas Steuber; Andrea Gallina; Jochen Walz; Paul Perrotte; Hartwig Huland; Markus Graefen; Pierre I Karakiewicz
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
European urology 2007;51(4):949-55; discussion 955.
2007: Pierre I Karakiewicz; Serge Benayoun; Louis R Bégin; AJ Duclos; Luc Valiquette; Michael McCormack; François Bénard; Fred Saad; Paul Perrotte
Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.
International journal of clinical practice 2007;61(3):425-30.
2006: Felix K-H Chun; Alberto Briganti; Elie Antebi; Markus Graefen; Eike Currlin; Thomas Steuber; Thorsten Schlomm; Jochen Walz; Alexander Haese; Martin G Friedrich; Sascha A Ahyai; Christian Eichelberg; Georg Salomon; Andrea Gallina; Andreas Erbersdobler; Paul Perrotte; Hans Heinzer; Hartwig Huland; Pierre I Karakiewicz
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.
BJU international 2006;98(6):1204-9.
2006: Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Paul Perrotte; Yair Lotan; Craig G Rogers; Gilad E Amiel; Amnon Vazina; Amit Gupta; Patrick J Bastian; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Precystectomy nomogram for prediction of advanced bladder cancer stage.
European urology 2006;50(6):1254-60; discussion 1261-2.
2006: Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Amiel E Gilad; Yair Lotan; Craig G Rogers; Amnon Vazina; Amit Gupta; Patrick J Bastian; Paul Perrotte; Arthur I Sagalowsky; Mark P Schoenberg; Seth P Lerner
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
The Journal of urology 2006;176(4 Pt 1):1354-61; discussion 1361-2.
2006: Pierre I Karakiewicz; Daniel J Lewinshtein; Felix K-H Chun; Alberto Briganti; Francois Guille; Paul Perrotte; Bernard Lobel; Vincenzo Ficarra; Walter Artibani; Luca Cindolo; Jacques Tostain; Claude C Abbou; Dominique Chopin; Alexandre de la Taille; Jean-Jacques Patard
Tumor size improves the accuracy of TNM predictions in patients with renal cancer.
European urology 2006;50(3):521-8; discussion 529.
2006: Pierre I Karakiewicz; Serge Benayoun; Daniel J Lewinshtein; Felix K-H Chun; Khaled Shahrour; Paul Perrotte
Treatment of BCG failures with intravesical BCG/Interferon: the University of Montreal experience.
The Canadian journal of urology 2006;13(4):3189-94.
2006: Christopher R Porter; Koichi Kodama; Robert P Gibbons; Roy Correa; Felix K-H Chun; Paul Perrotte; Pierre I Karakiewicz
25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series.
The Journal of urology 2006;176(2):569-74.
2006: Felix K-H Chun; Paul Perrotte; Alberto Briganti; Serge Benayoun; Thierry Lebeau; Alvaro Ramirez; Daniel J Lewinshtein; Luc Valiquette; Jean-Pierre Guay; Pierre I Karakiewicz
Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
BJU international 2006;98(1):50-3.
2006: Alvaro Ramirez; Serge Benayoun; Alberto Briganti; Jongi Chun; Paul Perrotte; Michael W Kattan; Markus Graefen; Michael McCormack; Alfred I Neugut; Fred Saad; Pierre I Karakiewicz
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges.
European urology 2006;50(1):58-62; discussion 62-3.
2006: Daniel J Lewinshtein; Paul Perrotte; Thierry Lebeau; Alvaro Ramirez; Serge Benayoun; Pierre I Karakiewicz
Normal urinary and sexual function in men without evidence of prostate cancer from Montreal, Canada.
BJU international 2006;97(6):1273-7.
2006: Fred Saad; Abdulhadi Al Dejmah; Paul Perrotte; Michael McCormack; François Bénard; Luc Valiquette; Pierre I Karakiewicz
Therapeutic approach to hormone-refractory prostate cancer.
The Canadian journal of urology 2006;13 Suppl 2():52-6.
2006: Pierre I Karakiewicz; Felix K-H Chun; Alberto Briganti; Paul Perrotte; Michael McCormack; François Bénard; Luc Valiquette; Markus Graefen; Fred Saad
Prostate cancer nomograms are superior to neural networks.
The Canadian journal of urology 2006;13 Suppl 2():18-25.
2006: Robert S Svatek; Pierre I Karakiewicz; Michael J Shulman; Jose A Karam; Paul Perrotte; Elie A Benaim
Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer.
European urology 2006;49(4):666-74.
2006: Thomas Steuber; Markus Graefen; Alexander Haese; Andreas Erbersdobler; Felix K-H Chun; Thorsten Schlom; Paul Perrotte; Hartwig Huland; Pierre I Karakiewicz
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
The Journal of urology 2006;175(3 Pt 1):939-44; discussion 944.
2006: Felix K-H Chun; Alberto Briganti; Thierry Lebeau; Vincent Fradet; Thomas Steuber; Jochen Walz; Thorsten Schlomm; Christian Eichelberg; Alexander Haese; Andreas Erbersdobler; Michael McCormack; Paul Perrotte; Markus Graefen; Hartwig Huland; Pierre I Karakiewicz
The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.
European urology 2006;49(2):273-8; discussion 278-9.
2005: Vincent Fradet; Michael McCormack; Paul Perrotte; Pierre I Karakiewicz; Fred Saad
An epidural abscess following transrectal ultrasound-guided biopsies of the prostate.
The Canadian journal of urology 2005;12(6):2899-900.
2005: Thierry Lebeau; Paul Perrotte; Luc Valiquette; François Bénard; Michael McCormack; Fred Saad; Pierre I Karakiewicz
Validation of prostate cancer index and SF-12 short forms.
The Canadian journal of urology 2005;12(6):2873-9.
2005: Pierre I Karakiewicz; Paul Perrotte; Luc Valiquette; Francois Benard; Michael McCormack; C Menard; M McNaughton Collins; J C Nickel
French-Canadian linguistic validation of the NIH Chronic Prostatitis Symptom Index.
The Canadian journal of urology 2005;12(5):2816-23.
2005: Fred Saad; Paul Perrotte; François Bénard; Michael McCormack; Pierre I Karakiewicz
Bone health in men with prostate cancer: diagnostic and therapeutic considerations.
The Canadian journal of urology 2005;12 Suppl 2():9-15.
2005: Pierre I Karakiewicz; Paul Perrotte; Mike McCormack; François Peloquin; Jean-Paul Perreault; Philippe Arjane; Hughes Widmer; Fred Saad
Early detection of prostate cancer with ultrasound-guided systematic needle biopsy.
The Canadian journal of urology 2005;12 Suppl 2():5-8.
2005: Pierre I Karakiewicz; Serge Benayoun; Michael W Kattan; Paul Perrotte; Luc Valiquette; Peter T Scardino; Ilias Cagiannos; Hans Heinzer; Simon Tanguay; Armen G Aprikian; Hartwig Huland; Markus Graefen
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
The Journal of urology 2005;173(6):1930-4.
2005: Shahrokh F Shariat; Craig D Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G Friedrich; Sanaa Eissa; Hideyuki Akaza; Ihor S Sawczuk; Vincenzo Serretta; Hartwig Huland; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I Sagalowsky; Frank H Wians; Claus G Roehrborn; Yair Lotan; Paul Perrotte; Serge Benayoun; Michael Marberger; Pierre I Karakiewicz
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
The Journal of urology 2005;173(5):1518-25.
2005: Pierre I Karakiewicz; Jean-Baptiste Lattouf; Paul Perrotte; Luc Valiquette; François Bénard; Michael McCormack; Catherine Ménard; Thierry Lebeau; Serge Benayoun; Alvaro Ramirez; Simon Ouaknine; Fred Saad
Validation of 1997 Partin Tables' lymph node invasion predictions in men treated with radical prostatectomy in Montreal Quebec.
The Canadian journal of urology 2005;12(2):2588-92.
2005: Alvaro Ramirez; Paul Perrotte; Luc Valiquette; Francois Benard; Michael McCormack; Fred Saad; Caroline Fournier; Shahrokh F Shariat; Pierre I Karakiewicz
Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patients.
The Canadian journal of urology 2005;12(1):2537-42.
2005: Fred Saad; Pierre I Karakiewicz; Paul Perrotte
The role of bisphosphonates in hormone-refractory prostate cancer.
World journal of urology 2005;23(1):14-8.
2004: Robert Sabbagh; Michael McCormack; François Péloquin; Raymond Faucher; Jean-Paul Perreault; Paul Perrotte; Pierre I Karakiewicz; Fred Saad
A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy.
The Canadian journal of urology 2004;11(2):2216-9.
2003: Lance C Pagliaro; Afsaneh Keyhani; Baoshun Liu; Paul Perrotte; Deborah Wilson; Colin P N Dinney
Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.
Urologic oncology 2003;21(6):456-62.
2003: Lance C Pagliaro; Afsaneh Keyhani; Dallas Williams; Denise Woods; Baoshun Liu; Paul Perrotte; Joel W Slaton; James A Merritt; H Barton Grossman; Colin P N Dinney
Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(12):2247-53.
2002: Jonathan I Izawa; Paul Sweeney; Paul Perrotte; Daniel Kedar; Zhongyun Dong; Joel W Slaton; Takashi Karashima; Keji Inoue; William F Benedict; Colin P N Dinney
Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(4):1258-70.
2001: Joel W Slaton; Takashi Karashima; Paul Perrotte; Keji Inoue; Sun J Kim; Jonathan I Izawa; Daniel Kedar; David J McConkey; Randall Millikan; Paul Sweeney; Chiaki Yoshikawa; Taro Shuin; Colin P N Dinney
Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2840-53.
2001: Jonathan I Izawa; Paul Perrotte; GF Greene; Shellie Scott; L Levy; Edward J McGuire; L Madsen; Andrew C von Eschenbach; Louis L Pisters
Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy.
The Journal of urology 2001;165(3):867-70.
2001: Joel W Slaton; K Inoue; Paul Perrotte; Adel K El-Naggar; David A Swanson; Isaiah J Fidler; C P Dinney
Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.
The American journal of pathology 2001;158(2):735-43.
2001: Jonathan I Izawa; Joel W Slaton; Daniel Kedar; Takashi Karashima; Paul Perrotte; Bogdan Czerniak; H Barton Grossman; Colin P N Dinney
Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder.
Oncology reports 2001;8(1):9-15.
2000: Keji Inoue; Joel W Slaton; Paul Perrotte; Darren W Davis; Christiane J Bruns; Daniel J Hicklin; David J McConkey; Paul Sweeney; Robert Radinsky; Colin P N Dinney
Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4874-84.
2000: Keji Inoue; Paul Perrotte; Christopher G Wood; Joel W Slaton; Paul Sweeney; Colin P N Dinney
Gene therapy of human bladder cancer with adenovirus-mediated antisense basic fibroblast growth factor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4422-31.
2000: Paul Perrotte; M Wood; Joel W Slaton; D R Wilson; L Pagliaro; R E Price; Colin P N Dinney
Biosafety of in vivo adenovirus-p53 intravesical administration in mice.
Urology 2000;56(1):155-9.
2000: Keji Inoue; Joel W Slaton; Beryl Y Eve; Sun J Kim; Paul Perrotte; MD Balbay; S Yano; Menashe Bar-Eli; Robert Radinsky; Curtis A Pettaway; Colin P N Dinney
Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):2104-19.
2000: Keji Inoue; Joel W Slaton; Sun J Kim; Paul Perrotte; Beryl Y Eve; Menashe Bar-Eli; Robert Radinsky; Colin P N Dinney
Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
Cancer research 2000;60(8):2290-9.
1999: Joel W Slaton; Paul Perrotte; Keji Inoue; Colin P N Dinney; Isaiah J Fidler
Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2726-34.
1999: Louis L Pisters; Paul Perrotte; Shellie M Scott; GF Greene; Andrew C von Eschenbach
Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2514-20.
1999: Paul Perrotte; M S Litwin; Edward J McGuire; Shellie M Scott; Andrew C von Eschenbach; Louis L Pisters
Quality of life after salvage cryotherapy: the impact of treatment parameters.
The Journal of urology 1999;162(2):398-402.
1999: Paul Perrotte; T Matsumoto; Keji Inoue; H Kuniyasu; Beryl Y Eve; Daniel J Hicklin; Robert Radinsky; Colin P N Dinney
Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):257-65.
1998: Colin P N Dinney; R C Babkowski; M Antelo; Paul Perrotte; Monica Liebert; H Z Zhang; J Palmer; Robert W Veltri; Ruth Katz; H Barton Grossman
Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder.
The Journal of urology 1998;160(4):1285-90.
1998: Colin P N Dinney; Diane R Bielenberg; Paul Perrotte; R Reich; Beryl Y Eve; Corazon D Bucana; Isaiah J Fidler
Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.
Cancer research 1998;58(4):808-14.